Glioblastoma immunotherapy: time for hope?
- PMID: 37700174
- DOI: 10.1007/s10072-023-07066-3
Glioblastoma immunotherapy: time for hope?
References
-
- Liau LM, Ashkan K, Brem S et al (2022) Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a Phase 3 prospective externally controlled cohort trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2022.5370 - DOI - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical